|
|
Volumn 6, Issue 7, 2005, Pages 612-614
|
|
Disease mongering and drug marketing. Does the pharmaceutical industry manufacture diseases as well as drugs?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATOMOXETINE;
ATORVASTATIN;
CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PAROXETINE;
SERTRALINE;
SIMVASTATIN;
ARTICLE;
ATTENTION DEFICIT DISORDER;
COMMERCIAL PHENOMENA;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG RESEARCH;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE SYSTEM;
HEALTH EDUCATION;
HUMAN;
HYPERCHOLESTEROLEMIA;
INFORMATION DISSEMINATION;
MEDICAL DECISION MAKING;
MEDICAL INFORMATION;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
PATIENT ATTITUDE;
PATIENT CARE;
PHYSICIAN ATTITUDE;
POSTTRAUMATIC STRESS DISORDER;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
SOCIAL ASPECT;
SOCIAL BEHAVIOR;
SOCIAL PHOBIA;
UNITED STATES;
ADVERTISING;
CONFLICT OF INTEREST;
DRUG INDUSTRY;
DRUG THERAPY;
HUMANS;
|
|
EID: 23744502929
PISSN: 1469221X
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.embor.7400476 Document Type: Article |
|
Times cited : (50)
|
|
References (2)
|
